Crossref
Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes
Clinical Medicine Reviews in Vascular Health · 2010
DOI: 10.4137/cmrvh.s4535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Vascular Health, 2010.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2010). Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. https://doi.org/10.4137/cmrvh.s4535
Vancouver
Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. 2010. doi:10.4137/cmrvh.s4535
BibTeX
@article{euvimed2010,
title = {Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes},
journal = {Clinical Medicine Reviews in Vascular Health},
year = {2010},
doi = {10.4137/cmrvh.s4535}
}
EUVIMED